Canine Oral Chewable Tablets Market: By Composition Type (Botanically synthesized, Chemically synthesized), By Drug Class (Analgesics, Anti-infective, Anti-ulcers, Vitamins & minerals, Cardiovascular drugs, Others), By Application (Gastrointestinal diseases, Cardiovascular disorders, Infectious diseases, Nutritional supplements, Others), By Product Type (Prescription, Over the Counter (OTC)), By Distribution Channel (Veterinary clinics, Veterinary Pharmacies, Online veterinary stores, Others) and Geography

Purchase Option

Single User License $ 4400

Multiple User License $ 6600

Corporate User License $ 8900

Canine Oral Chewable Tablets Market size was valued at USD X million in 2023 and is poised to grow at a CAGR of x% from 2024 - 2030. Canine Oral Chewable Tablets Market is an oral dosage form of medication with additives used to treat various types of canine diseases such as arthritis, canine congestive heart failure, tick and flea infections, and among others. Various additives and flavoring agents are used in the formulation of canine oral chewable tablets to mask the unpleasant taste and odor of the drugs. The canine oral chewable tablets will dissolve in 2-5 minutes and the pharmacological action takes place immediately. The global canine oral chewable tablets market is in the developing stage as several local and international players are actively engaged in the manufacturing of canine oral chewable tablets for the treatment of chronic canine diseases. Acquisitions and mergers, collaborations, joint ventures, and product launches, are some key strategies followed by the manufacturers for increasing their share in the global market.

Canine Oral Chewable Tablets Market Key Developments:

in May 2014, Merck Animal Health received the FDA approval for its drug Bravecto (fluralaner) used in the treatment of fleas and ticks infections. Moreover,
in December 2014, Putney, Inc. launched the Carprofen canine oral chewable tablets for the treatment of pain and inflammation.

Global Canine Oral Chewable Tablets Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

Largest Market

Asia-Pacific

Fastest Growing Market

North America

Canine Oral Chewable Tablets Market Dynamics

Rise in the expenditure in animal welfare and wellness, wider availability of the canine oral chewable tablets in the market, and rise in the prevalence of various canine diseases such as tick and fleas infections, anticipated to fuel the global market over the forecast period. In addition, ease of administration of tablets compared with parenteral formulations, lack of nutrition values in the canine feed, and initiations taken by various pet organizations and NGOs for animal welfare are expected bolster the canine oral chewable tablets market over the forecast years. However, stringent regulatory policies for the approval of veterinary formulations, lack of awareness about the canine oral chewable tablets in rural areas, high cost of the products, and withdrawn of drugs from the market such as levothyroxine sodium due to FDA warning regarding the lack of approval might hinder the global market growth in the coming future.

North-America Got Significant Share

Canine Oral Chewable Tablets Market Regional Analysis

Geographically, canine oral chewable tablets market is segmented into the following regions Viz. Europe, Latin America, Asia Pacific, North America, and the Middle East and Africa. North America holds a significant share in global canine oral chewable tablets owing to increase in the adoption of canines (according to American Pet Products Association, approximately 78 Mn canines were owned in the U.S.), rise in the awareness of canines health, growth in the expenditure on animal welfare, increase in the research and development activities for the innovation of new products for chronic canine diseases might fuel the in the region. Asia Pacific accounts for key share, which is attributed to increasing in the prevalence of various canine microbial diseases due to unhygienic conditions, a rise in the expenditure on animal welfare, and diversification of business segment in Asia Pacific region by various manufacturers might bolster the canine oral chewable tablets market in Asia Pacific region. Europe holds a major share owing to increase the awareness about pets health, a rise in the prevalence of various canine diseases, lack of nutrition fortified canine feed, and rise in research and development activities for the canine oral chewable tablets market might propel the market growth in Europe region.

Latin America

Europe

Asia Pacific

Middle East

North America

Global Canine Oral Chewable Tablets Market Segmentation

By composition type

Botanically synthesized
Chemically synthesized

By Drugs Type

Analgesics
Anti-infective
Anti-ulcers
Vitamins & minerals
Cardiovascular drugs
Others

By Application

Gastrointestinal diseases
Cardiovascular disorders
Infectious diseases
Nutritional supplements
Others

By Distribution Channel

Veterinary clinics
Veterinary Pharmacies
Online veterinary stores
Others

Frequently Asked Questions

The canine oral chewable tablets market size was valued at USD x million in 2023

The Canine Oral Chewable Tablets Market key players are: Zoetis, Inc. (Pfizer) (U.S) Virbac AH Inc. (France) Elanco (Eli Lilly and Co.) (U.S.) Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany) Pala-Tech Laboratories (U.S.) Bayer HealthCare LLC, (Bayer AG) (Germany) Merck Animal Health (Merck &co. Inc.) (U.S.) Putney, Inc. (Dechra Pharmaceuticals) (U.K.)

The Canine Oral Chewable Tablets Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Key Features of the Report

The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments, and start-up details that are actively working in the market
The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

1. Executive summary

2. Global Canine Oral Chewable Tablets Market Introduction

2.1. Global Canine Oral Chewable Tablets Market Taxonomy

2.2. Global Canine Oral Chewable Tablets Market Definitions

2.2.1. Composition Type

2.2.2. Drug Class

3. Global Canine Oral Chewable Tablets Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Canine Oral Chewable Tablets Market Dynamics Factors Impact Analysis

3.6. Global Canine Oral Chewable Tablets Market Recent Market Introductions

4. Global Canine Oral Chewable Tablets Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030

4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Oppurtunity Analysis

5. Global Canine Oral Chewable Tablets Market Forecast, By Composition Type, 2019 - 2023 and Forecast, 2024 - 2030

5.1. Botanically Synthesized

5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Chemically Synthesized

5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

6. Global Canine Oral Chewable Tablets Market Forecast, By Drug Class, 2019 - 2023 and Forecast, 2024 - 2030
6.1. Analgesics

6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Anti-infective

6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Anti-ulcers

6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Vitamins & Minerals

6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

6.5. Cardiovascular Drugs

6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.5.3. Market Opportunity Analysis

6.6. Others

6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.6.3. Market Opportunity Analysis

7. Global Canine Oral Chewable Tablets Market Forecast, By Application, 2019 - 2023 and Forecast, 2024 - 2030

7.1. Gastrointestinal Diseases

7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Cardiovascular Disorders

7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Cardiovascular Disorders

7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

7.4. Cardiovascular Disorders

7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.4.3. Market Opportunity Analysis

7.5. Others

7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.5.3. Market Opportunity Analysis

8. Global Canine Oral Chewable Tablets Market Forecast, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2030

8.1. Veterinary Clinics

8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Veterinary Pharmacies

8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Online Veterinary Pharmacies

8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Others

8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

9. Global Canine Oral Chewable Tablets Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030

9.1. North America

9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.1.3. Market Opportunity Analysis

9.2. Europe

9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.2.3. Market Opportunity Analysis

9.3. Asia-Pacific

9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.3.3. Market Opportunity Analysis

9.4. Latin America

9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.4.3. Market Opportunity Analysis

9.5. Middle East and Africa

9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)

9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.5.3. Market Opportunity Analysis

9.6. Global Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Region, 2024 - 2030

10. North America Canine Oral Chewable Tablets Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030

10.1. Composition Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.1.1. Botanically Synthesized

10.1.2. Chemically Synthesized

10.2. Drug Class Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.2.1. Analgesics

10.2.2. Anti-infective

10.2.3. Anti-ulcers

10.2.4. Vitamins & Minerals

10.2.5. Cardiovascular Drugs

10.2.6. Others

10.3. Application Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.3.1. Gastrointestinal Diseases

10.3.2. Cardiovascular Disorders

10.3.3. Infectious Diseases

10.3.4. Nutritional Supplements

10.3.5. Others

10.4. Distribution Channel Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.4.1. Veterinary Clinics

10.4.2. Veterinary Pharmacies

10.4.3. Online Veterinary Pharmacies

10.4.4. Others

10.5. Country Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.5.1. U.S.

10.5.2. Canada

10.6. North America Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2024 - 2030

10.7. North America Canine Oral Chewable Tablets Market Dynamics Trends

11. Europe Canine Oral Chewable Tablets Market Analysis, 2024 - 2030 and Forecast, 2024 - 2030

11.1. Composition Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.1.1. Botanically Synthesized

11.1.2. Chemically Synthesized

11.2. Drug Class Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.2.1. Analgesics

11.2.2. Anti-infective

11.2.3. Anti-ulcers

11.2.4. Vitamins & Minerals

11.2.5. Cardiovascular Drugs

11.2.6. Others

11.3. Application Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.3.1. Gastrointestinal Diseases

11.3.2. Cardiovascular Disorders

11.3.3. Infectious Diseases

11.3.4. Nutritional Supplements

11.3.5. Others

11.4. Distribution Channel Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.4.1. Veterinary Clinics

11.4.2. Veterinary Pharmacies

11.4.3. Online Veterinary Pharmacies

11.4.4. Others

11.5. Country Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.5.1. Germany

11.5.2. UK

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Russia

11.5.7. Poland

11.5.8. Rest of Europe

11.6. Europe Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2024 - 2030

11.7. Europe Canine Oral Chewable Tablets Market Dynamics Trends

12. Asia-Pacific Canine Oral Chewable Tablets Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030

12.1. Composition Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.1.1. Botanically Synthesized

12.1.2. Chemically Synthesized

12.2. Drug Class Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.2.1. Analgesics

12.2.2. Anti-infective

12.2.3. Anti-ulcers

12.2.4. Vitamins & Minerals

12.2.5. Cardiovascular Drugs

12.2.6. Others

12.3. Application Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.3.1. Gastrointestinal Diseases

12.3.2. Cardiovascular Disorders

12.3.3. Infectious Diseases

12.3.4. Nutritional Supplements

12.3.5. Others

12.4. Distribution Channel Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.4.1. Veterinary Clinics

12.4.2. Veterinary Pharmacies

12.4.3. Online Veterinary Pharmacies

12.4.4. Others

12.5. Country Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)

12.5.1. Japan

12.5.2. China

12.5.3. India

12.5.4. ASEAN

12.5.5. Australia & New Zealand

12.5.6. Rest of Asia-Pacific

12.6. Asia-Pacific Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2024 - 2030

12.7. Asia-Pacific Canine Oral Chewable Tablets Market Dynamics Trends

13. Latin America Canine Oral Chewable Tablets Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030

13.1. Composition Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.1.1. Botanically Synthesized

13.1.2. Chemically Synthesized

13.2. Drug Class Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.2.1. Analgesics

13.2.2. Anti-infective

13.2.3. Anti-ulcers

13.2.4. Vitamins & Minerals

13.2.5. Cardiovascular Drugs

13.2.6. Others

13.3. Application Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.3.1. Gastrointestinal Diseases

13.3.2. Cardiovascular Disorders

13.3.3. Infectious Diseases

13.3.4. Nutritional Supplements

13.3.5. Others

13.4. Distribution Channel Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.4.1. Veterinary Clinics

13.4.2. Veterinary Pharmacies

13.4.3. Online Veterinary Pharmacies

13.4.4. Others

13.5. Country Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Argentina

13.5.4. Venezuela

13.5.5. Rest of Latin America

13.6. Latin America Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2024 - 2030

13.7. Latin America Canine Oral Chewable Tablets Market Dynamics Trends

14. Middle East & Africa Canine Oral Chewable Tablets Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030

14.1. Composition Type Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.1.1. Botanically Synthesized

14.1.2. Chemically Synthesized

14.2. Drug Class Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.2.1. Analgesics

14.2.2. Anti-infective

14.2.3. Anti-ulcers

14.2.4. Vitamins & Minerals

14.2.5. Cardiovascular Drugs

14.2.6. Others

14.3. Application Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.3.1. Gastrointestinal Diseases

14.3.2. Cardiovascular Disorders

14.3.3. Infectious Diseases

14.3.4. Nutritional Supplements

14.3.5. Others

14.4. Distribution Channel Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.4.1. Veterinary Clinics

14.4.2. Veterinary Pharmacies

14.4.3. Online Veterinary Pharmacies

14.4.4. Others

14.5. Country Analysis (2019 - 2023) and Forecast (2024 - 2030) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.5.1. Gulf Cooperation Council (GCC) Countries

14.5.2. Israel

14.5.3. South Africa

14.5.4. Rest of MEA

14.6. MEA Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2024 - 2030

14.7. MEA Canine Oral Chewable Tablets Market Dynamics Trends

15. Competition Landscape

15.1. Strategic Dashboard of Top Market Players

15.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)

15.2.1. Zoetis, Inc. (Pfizer) (U.S)

15.2.2. Virbac AH Inc. (France)

15.2.3. Elanco (Eli Lilly and Co.) (U.S.)

15.2.4. Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany)

15.2.5. Pala-Tech Laboratories (U.S.)

15.2.6. Bayer HealthCare LLC, (Bayer AG) (Germany)

15.2.7. Merck Animal Health (Merck &co. Inc.) (U.S.)

15.2.8. Putney, Inc. (Dechra Pharmaceuticals) (U.K.)

16. Research Methodology
17. Key Assumptions and Acronyms

Zoetis, Inc. (Pfizer) (U.S)
Virbac AH Inc. (France)
Elanco (Eli Lilly and Co.) (U.S.)
Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany)
Pala-Tech Laboratories (U.S.)
Bayer HealthCare LLC, (Bayer AG) (Germany)
Merck Animal Health (Merck &co. Inc.) (U.S.)
Putney, Inc. (Dechra Pharmaceuticals) (U.K.)

Adjacent Markets

High Throughput Screening Market

Biomaterials Market

Biomimetics Market

Hollow Fiber Filtration Market

Laboratory Filtration Market

Switzerland Spinal MRI Procedures Market